Kothari Fermentation and Biochem Limited (KFBL.BO)

Kothari Fermentation and Biochem Limited (KFBL.BO) — VMCI valuation read

Kothari Fermentation and Biochem Limited (KFBL.BO) carries a VMCI composite of 44/100, 6 points below the Consumer Defensive sector median of 50. Among mid-cap names, that gap places KFBL.BO in the bottom third on the five-pillar weighting (Value 35%, Quality 30%, Integrity 15%, Growth 12%, Risk 8%).

The KFBL.BO insider tape has been silent for the past 30 days on Form 4. Where executives neither buy nor sell, the bull and bear cases lean harder on filings cadence and the next earnings line.

**Investor frame.** Value reads KFBL.BO trades at 22.0x earnings, 22% above the Consumer Defensive median of 18.0x, which compresses or extends through the 11.0x EV/EBITDA versus a Consumer Defensive 12.0x. Quality: ROIC of 18.0% sits 8.0pp above the Consumer Defensive median (10.0%). Risk: net debt to EBITDA of -1.9x leaves covenant headroom, the line to track on Kothari Fermentation and Biochem Limited's next 10-Q.

KFBL.BO fell 2.8% over the trailing 7 days, with a -10.6% read on a 30-day basis.